<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">hepato</journal-id><journal-title-group><journal-title xml:lang="ru">Анналы хирургической гепатологии</journal-title><trans-title-group xml:lang="en"><trans-title>Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-5464</issn><issn pub-type="epub">2408-9524</issn><publisher><publisher-name>НЭИКОН ИСП</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.16931/1995-5464.2023-1-33-40</article-id><article-id custom-type="elpub" pub-id-type="custom">hepato-946</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПЕЧЕНЬ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LIVER</subject></subj-group></article-categories><title-group><article-title>Результаты повторных трансплантаций печени</article-title><trans-title-group xml:lang="en"><trans-title>Results of liver retransplantations</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8415-946X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Боровик</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Borovik</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Боровик Владимир Владимирович – канд. мед. наук, ведущий научный сотрудник отдела интервенционной радиологии и оперативной хирургии</p><p>197758, Санкт-Петербург, ул. Ленинградская, д. 70</p><p>+7-921-952-13-11</p></bio><bio xml:lang="en"><p>Vladimir V. Borovik – Сand. of Sci. (Med.), Leading Researcher, Surgery and Interventional Radiology Unit</p><p>70, Leningradskaya str., St. Petersburg, 197758</p><p>+7-921-952-13-11</p></bio><email xlink:type="simple">borovik1968@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тилеубергенов</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tileubergenov</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тилеубергенов Инхат Ибрагимович – канд. мед. наук, руководитель группы трансплантационной хирургии</p><p>197758, Санкт-Петербург, ул. Ленинградская, д. 70</p></bio><bio xml:lang="en"><p>Inkhat I. Tileubergenov – Сand. of Sci. (Med.), Head of Transplantation Surgery Group</p><p>70, Leningradskaya str., St. Petersburg, 197758</p></bio><email xlink:type="simple">inkhat@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9018-0433</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Руткин</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rutkin</surname><given-names>I. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Руткин Игорь Олегович – канд. мед. наук, заместитель главного врача по хирургии</p><p>197758, Санкт-Петербург, ул. Ленинградская, д. 70</p></bio><bio xml:lang="en"><p>Igor O. Rutkin – Сand. of Sci. (Med.), Deputy Chief Physician for Surgery</p><p>70, Leningradskaya str., St. Petersburg, 197758</p></bio><email xlink:type="simple">operblock@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8174-7461</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Майстренко</surname><given-names>Д. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Maystrenko</surname><given-names>D. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Майстренко Дмитрий Николаевич – доктор мед. наук, директор</p><p>197758, Санкт-Петербург, ул. Ленинградская, д. 70</p></bio><bio xml:lang="en"><p>Dmitriy N. Maystrenko – Doct. of Sci. (Med.), Director</p><p>70, Leningradskaya str., St. Petersburg, 197758</p></bio><email xlink:type="simple">may64@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8746-8452</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гранов</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Granov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гранов Дмитрий Анатольевич – доктор мед. наук, профессор, академик РАН, научный руководитель</p><p>197758, Санкт-Петербург, ул. Ленинградская, д. 70</p></bio><bio xml:lang="en"><p>Dmitrii A. Granov – Doct. of Sci. (Med.), Professor, Academician of the Russian Academy of Sciences, Supervisor of the Department of Science</p><p>70, Leningradskaya str., St. Petersburg, 197758</p></bio><email xlink:type="simple">dmitriigranov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ “Российский научный центр радиологии и хирургических технологий им. академика А.М. Гранова” Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>19</day><month>03</month><year>2023</year></pub-date><volume>28</volume><issue>1</issue><fpage>33</fpage><lpage>40</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Боровик В.В., Тилеубергенов И.И., Руткин И.А., Майстренко Д.Н., Гранов Д.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Боровик В.В., Тилеубергенов И.И., Руткин И.А., Майстренко Д.Н., Гранов Д.А.</copyright-holder><copyright-holder xml:lang="en">Borovik V.V., Tileubergenov I.I., Rutkin I.O., Maystrenko D.N., Granov D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://hepato.elpub.ru/jour/article/view/946">https://hepato.elpub.ru/jour/article/view/946</self-uri><abstract><sec><title>Цель</title><p>Цель. Представление результатов повторных трансплантаций печени, выполненных в федеральном центре.  </p></sec><sec><title>Материал и методы</title><p>Материал и методы. Анализировали результаты 268 ортотопических трансплантаций полноразмерной посмертной печени у 248 больных с 1998 г. Повторная трансплантация выполнена 20 (8,1%) больным – 10 мужчинам и 10 женщинам 18–64 лет (медиана 44,4 года). Медиана тяжести состояния больных по MELD составила 21 балл (19–24). Наблюдения до 2006 г. анализировали ретроспективно. У большинства больных показаниями к повторной пересадке стали ранний тромбоз печеночной артерии и поздние билиарные осложнения вследствие недостаточности артериального кровоснабжения трансплантата.  </p></sec><sec><title>Результаты</title><p>Результаты. Продолжительность этапов консервации была сопоставима с первичной трансплантацией. Достоверная разница получена в продолжительности беспеченочного периода, объеме гемотрансфузии, продолжительности операции, частоте осложнений и госпитальной летальности. В настоящее время живы 9 (45%) из 20 пациентов, срок наблюдения – 7–140 мес. Функция трансплантата у большинства реципиентов удовлетворительная. Госпитальная летальность составила 35%.  </p></sec><sec><title>Заключение</title><p>Заключение. Ретрансплантация печени сопровождается значительными техническими трудностями, увеличением продолжительности операции, объема гемотрансфузии, времени пребывания в отделении интенсивной терапии, а также частоты послеоперационных осложнений. Основной причиной смерти пациентов были инфекционные осложнения. При успешном выполнении ретрансплантации отдаленные результаты и выживаемость сопоставимы с результатами первичной трансплантации. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To present the results of repeated liver transplantations performed in a federal center.  </p></sec><sec><title>Materials and methods</title><p>Materials and methods. The results of 268 orthotopic full-liver postmortem transplantations in 248 patients since 1998 were analyzed. Retransplantation was performed in 20 patients (8.1%) – 10 men and 10 women, 18-64 years old (median age 44.4 years). The median MELD score was 21 (19-24). Observations before 2006 were analyzed retrospectively. Early hepatic artery thrombosis and late biliary complications due to insufficient arterial blood supply to the graft indicated the retransplantation in the majority of patients.  </p></sec><sec><title>Results</title><p>Results. The duration of preservation stages was comparable to the primary transplantation. Significant differences were found in the duration of the anhepatic period, the volume of hemotransfusion, the duration of the surgery, the rate of complications and the hospital mortality rate. Currently, 9 of the 20 patients (45%) are alive, with a follow-up period of 7-140 months. Graft function was satisfactory in most recipients. Hospital mortality accounted for 35%.  </p></sec><sec><title>Conclusion</title><p>Conclusion. Liver retransplantation is accompanied by considerable technical difficulties, as well as by an increase in surgery duration, volume of blood transfusion, time of stay in the intensive care unit, and incidence of postoperative complications. Infectious complications were the main cause of death. With successful retransplantation, long-term results and survival rates were comparable to those of primary transplantation. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>печень</kwd><kwd>повторная трансплантация</kwd><kwd>нефункционирование трансплантата</kwd><kwd>артериальные осложнения</kwd><kwd>потеря трансплантата</kwd><kwd>билиарные осложнения</kwd><kwd>сепсис</kwd></kwd-group><kwd-group xml:lang="en"><kwd>liver</kwd><kwd>retransplantation</kwd><kwd>graft failure</kwd><kwd>arterial complications</kwd><kwd>graft loss</kwd><kwd>biliary complications</kwd><kwd>sepsis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zarrinpar A., Hong J.C. What is the prognosis after retransplantation of the liver? Adv. Surg. 2012; 46: 87–100. https://doi.org/10.1016/j.yasu.2012.03.005.</mixed-citation><mixed-citation xml:lang="en">Zarrinpar A., Hong J.C. What is the prognosis after retransplantation of the liver? Adv. Surg. 2012; 46: 87–100. https://doi.org/10.1016/j.yasu.2012.03.005.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rana A., Petrowsky H., Kaplan B., Jie T., Porubsky M., Habib S., Rilo H., Gruessner A., Gruessner R. Early liver retransplantation in adults. Transpl. Int. 2014; 27 (2): 141–151. https://doi.org/10.1111/tri.12201</mixed-citation><mixed-citation xml:lang="en">Rana A., Petrowsky H., Kaplan B., Jie T., Porubsky M., Habib S., Rilo H., Gruessner A., Gruessner R. Early liver retransplantation in adults. Transpl. Int. 2014; 27 (2): 141–151. https://doi.org/10.1111/tri.12201</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bellido C.B., Martínez J.M.A., Gómez L.M.M., Artacho G.S., Diez-Canedo J.S., Pulido L.B., Acevedo J.M.P., Bravo M.A.G. Indications for and survival after liver retransplantation. Transplant. Proc. 2010; 42 (2): 637–640. https://doi.org/10.1016/j.transproceed.2010.02.017</mixed-citation><mixed-citation xml:lang="en">Rana A., Petrowsky H., Kaplan B., Jie T., Porubsky M., Habib S., Rilo H., Gruessner A., Gruessner R. Early liver retransplantation in adults. Transpl. Int. 2014; 27 (2): 141–151. https://doi.org/10.1111/tri.12201</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004; 240 (2): 205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae</mixed-citation><mixed-citation xml:lang="en">Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004; 240 (2): 205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Цирульникова О.М., Умрик Д.В., Милосердов И.А., Егорова Е.Т., Латыпов Р.А. Эффективность и безопасность препаратов прямого противовирусного действия у реципиентов печени с рецидивом хронического гепатита с 1-го генотипа после трансплантации. Вестник трансплантологии и искусственных органов. 2018; 20 (4): 61–68. https://doi.org/10.15825/1995-1191-2018-4-61-68 Tsiroulnikova O.M., Umrik D.V., Miloserdov I.A., Egorova E.T., Latypov R.A. The efficacy and safety of antiviral drugs of direct action in liver recipients with recurrence of chronic hepatitis C genotype 1 after transplantation. Russian Journal of Transplantology and Artificial Organs. 2018; 20 (4): 61–68. https://doi.org/10.15825/1995-1191-2018-4-61-68 (In Russian)</mixed-citation><mixed-citation xml:lang="en">Bellido C.B., Martínez J.M.A., Gómez L.M.M., Artacho G.S., Diez-Canedo J.S., Pulido L.B., Acevedo J.M.P., Bravo M.A.G. Indications for and survival after liver retransplantation. Transplant. Proc. 2010; 42 (2): 637–640. https://doi.org/10.1016/j.transproceed.2010.02.017</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Сюткин В.Е., Бессонова Е.Н., Давыденко М.Н. Терапия возвратного гепатита С после трансплантации печени препаратами прямого противовирусного действия: опыт трех российских центров. Эпидемиология и инфекционные болезни. 2018; 23 (1): 4–14. https://doi.org/10.18821/1560- 9529-2018-23-1-4-14 Syutkin V.E., Bessonova E.N., Davydenko M.N. Therapy of recurrent hepatitis C after transplantation of the liver with direct acting anti-hepatitis C virus drugs: experience of three Russian centers. Epidemiology and Infectious Diseases. 2018; 23 (1): 4–14. https://doi.org/10.18821/1560-9529-2018-23-1-4-14 (In Russian)</mixed-citation><mixed-citation xml:lang="en">Сюткин В.Е., Бессонова Е.Н., Давыденко М.Н. Терапия возвратного гепатита С после трансплантации печени препаратами прямого противовирусного действия: опыт трех российских центров. Эпидемиология и инфекционные болезни. 2018; 23 (1): 4–14. https://doi.org/10.18821/1560- 9529-2018-23-1-4-14 Syutkin V.E., Bessonova E.N., Davydenko M.N. Therapy of recurrent hepatitis C after transplantation of the liver with direct acting anti-hepatitis C virus drugs: experience of three Russian centers. Epidemiology and Infectious Diseases. 2018; 23 (1): 4–14. https://doi.org/10.18821/1560-9529-2018-23-1-4-14 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Montano-Loza A.J., Bhanji R.A., Wasilenko S., Mason A.L. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Aliment. Pharmacol. Ther. 2017; 45 (4): 485–500. https://doi.org/10.1111/apt.13894</mixed-citation><mixed-citation xml:lang="en">Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004; 240 (2): 205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Новрузбеков М.С., Олисов О.Д. Сосудистые осложнения после ортотопической трансплантации печени. Транспланто логия. 2017; 9 (1): 35–50. https://doi.org/10.23873/2074- 0506-2017-9-1-35-50 Novruzbekov M.S., Olisov O.D. Vascular complications after orthotopic liver transplantation. Transplantologiya. 2017; 9 (1): 35–50. https://doi.org/10.23873/2074-0506-2017-9-1-35-50 (In Russian)</mixed-citation><mixed-citation xml:lang="en">Новрузбеков М.С., Олисов О.Д. Сосудистые осложнения после ортотопической трансплантации печени. Транспланто логия. 2017; 9 (1): 35–50. https://doi.org/10.23873/2074- 0506-2017-9-1-35-50 Novruzbekov M.S., Olisov O.D. Vascular complications after orthotopic liver transplantation. Transplantologiya. 2017; 9 (1): 35–50. https://doi.org/10.23873/2074-0506-2017-9-1-35-50 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Collins K.M., Doyle M.B.M., Chapman W.C. Orthotopic liver transplantation. In: Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2 Volume Set (Sixth Edition). 2017; 2: 1801– 1815. https://doi.org/10.1016/B978-1-4377-1454-8.00098-9</mixed-citation><mixed-citation xml:lang="en">Цирульникова О.М., Умрик Д.В., Милосердов И.А., Егорова Е.Т., Латыпов Р.А. Эффективность и безопасность препаратов прямого противовирусного действия у реципиентов печени с рецидивом хронического гепатита с 1-го генотипа после трансплантации. Вестник трансплантологии и искусственных органов. 2018; 20 (4): 61–68. https://doi.org/10.15825/1995-1191-2018-4-61-68 Tsiroulnikova O.M., Umrik D.V., Miloserdov I.A., Egorova E.T., Latypov R.A. The efficacy and safety of antiviral drugs of direct action in liver recipients with recurrence of chronic hepatitis C genotype 1 after transplantation. Russian Journal of Transplantology and Artificial Organs. 2018; 20 (4): 61–68. https://doi.org/10.15825/1995-1191-2018-4-61-68 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Schielke A., Scatton O., Boelle P.-Y., Perdigao F., Bernard D., Soubrane O., Conti F. Ischemic-type biliary lesions: a leading indication of liver retransplantation with excellent results. Clin. Res. Hepatol. Gastroenterol. 2019; 43 (2): 131–139. https://doi.org/10.1016/j.clinre.2017.11.005.</mixed-citation><mixed-citation xml:lang="en">Schielke A., Scatton O., Boelle P.-Y., Perdigao F., Bernard D., Soubrane O., Conti F. Ischemic-type biliary lesions: a leading indication of liver retransplantation with excellent results. Clin. Res. Hepatol. Gastroenterol. 2019; 43 (2): 131–139. https://doi.org/10.1016/j.clinre.2017.11.005.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hartog H., Hann A., Perera M.T.P.R. Primary nonfunction of the liver allograft. Transplantation. 2022; 106 (1): 117–128. https://doi.org/10.1097/TP.0000000000003682</mixed-citation><mixed-citation xml:lang="en">Сюткин В.Е., Бессонова Е.Н., Давыденко М.Н. Терапия возвратного гепатита С после трансплантации печени препаратами прямого противовирусного действия: опыт трех российских центров. Эпидемиология и инфекционные болезни. 2018; 23 (1): 4–14. https://doi.org/10.18821/1560- 9529-2018-23-1-4-14 Syutkin V.E., Bessonova E.N., Davydenko M.N. Therapy of recurrent hepatitis C after transplantation of the liver with direct acting anti-hepatitis C virus drugs: experience of three Russian centers. Epidemiology and Infectious Diseases. 2018; 23 (1): 4–14. https://doi.org/10.18821/1560-9529-2018-23-1-4-14 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Takagi K., Domagala P., Porte R.J., Alwayn I., Metselaar H.J., van den Berg A.P., van Hoek B., Ijzermans J.N.M., Polak W.G. Liver retransplantation in adult recipients: analysis of a 38-year experience in the Netherlands. J. Hepatobiliary Pancreat. Sci. 2020; 27 (1): 26–33. https://doi.org/10.1002/jhbp.701</mixed-citation><mixed-citation xml:lang="en">Takagi K., Domagala P., Porte R.J., Alwayn I., Metselaar H.J., van den Berg A.P., van Hoek B., Ijzermans J.N.M., Polak W.G. Liver retransplantation in adult recipients: analysis of a 38-year experience in the Netherlands. J. Hepatobiliary Pancreat. Sci. 2020; 27 (1): 26–33. https://doi.org/10.1002/jhbp.701</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Marudanayagam R., Shanmugam V., Sandhu B., Gunson B.K., Mirza D.F., Mayer D., Buckels J., Bramhall S.R. Liver retransplantation in adults: a single-centre, 25-year experience. HPB (Oxford). 2010; 12 (3): 217–224. https://doi.org/10.1111/j.1477-2574.2010.00162.x</mixed-citation><mixed-citation xml:lang="en">Montano-Loza A.J., Bhanji R.A., Wasilenko S., Mason A.L. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Aliment. Pharmacol. Ther. 2017; 45 (4): 485–500. https://doi.org/10.1111/apt.13894</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lladó L., Lopez-Dominguez J., Ramos E., Cachero A., Mils K., Baliellas C., Busquets J., Fabregat J. Is liver retransplantation justified in the current era? Cir. Esp. 2021; 99 (5): 339–345. https://doi.org/10.1016/j.ciresp.2020.06.023</mixed-citation><mixed-citation xml:lang="en">Lladó L., Lopez-Dominguez J., Ramos E., Cachero A., Mils K., Baliellas C., Busquets J., Fabregat J. Is liver retransplantation justified in the current era? Cir. Esp. 2021; 99 (5): 339–345. https://doi.org/10.1016/j.ciresp.2020.06.023</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Salimi J., Jafarian A., Fakhar N., Ramandi A., Behzadi M., Moeni A., Dashti H., Najafi A., Shariat M.R., Makarem J., Khamneh A.C. Study of re-transplantation and prognosis in liver transplant center in Iran. Gastroenterol. Hepatol. Bed. Bench. 2021; 14 (3): 237–242. PMID: 34221263; PMCID: PMC8245839</mixed-citation><mixed-citation xml:lang="en">Новрузбеков М.С., Олисов О.Д. Сосудистые осложнения после ортотопической трансплантации печени. Транспланто логия. 2017; 9 (1): 35–50. https://doi.org/10.23873/2074- 0506-2017-9-1-35-50 Novruzbekov M.S., Olisov O.D. Vascular complications after orthotopic liver transplantation. Transplantologiya. 2017; 9 (1): 35–50. https://doi.org/10.23873/2074-0506-2017-9-1-35-50 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Collins K.M., Doyle M.B.M., Chapman W.C. Orthotopic liver transplantation. In: Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2 Volume Set (Sixth Edition). 2017; 2: 1801– 1815. https://doi.org/10.1016/B978-1-4377-1454-8.00098-9</mixed-citation><mixed-citation xml:lang="en">Collins K.M., Doyle M.B.M., Chapman W.C. Orthotopic liver transplantation. In: Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2 Volume Set (Sixth Edition). 2017; 2: 1801– 1815. https://doi.org/10.1016/B978-1-4377-1454-8.00098-9</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Schielke A., Scatton O., Boelle P.-Y., Perdigao F., Bernard D., Soubrane O., Conti F. Ischemic-type biliary lesions: a leading indication of liver retransplantation with excellent results. Clin. Res. Hepatol. Gastroenterol. 2019; 43 (2): 131–139. https://doi.org/10.1016/j.clinre.2017.11.005.</mixed-citation><mixed-citation xml:lang="en">Schielke A., Scatton O., Boelle P.-Y., Perdigao F., Bernard D., Soubrane O., Conti F. Ischemic-type biliary lesions: a leading indication of liver retransplantation with excellent results. Clin. Res. Hepatol. Gastroenterol. 2019; 43 (2): 131–139. https://doi.org/10.1016/j.clinre.2017.11.005.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hartog H., Hann A., Perera M.T.P.R. Primary nonfunction of the liver allograft. Transplantation. 2022; 106 (1): 117–128. https://doi.org/10.1097/TP.0000000000003682</mixed-citation><mixed-citation xml:lang="en">Hartog H., Hann A., Perera M.T.P.R. Primary nonfunction of the liver allograft. Transplantation. 2022; 106 (1): 117–128. https://doi.org/10.1097/TP.0000000000003682</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Takagi K., Domagala P., Porte R.J., Alwayn I., Metselaar H.J., van den Berg A.P., van Hoek B., Ijzermans J.N.M., Polak W.G. Liver retransplantation in adult recipients: analysis of a 38-year experience in the Netherlands. J. Hepatobiliary Pancreat. Sci. 2020; 27 (1): 26–33. https://doi.org/10.1002/jhbp.701</mixed-citation><mixed-citation xml:lang="en">Takagi K., Domagala P., Porte R.J., Alwayn I., Metselaar H.J., van den Berg A.P., van Hoek B., Ijzermans J.N.M., Polak W.G. Liver retransplantation in adult recipients: analysis of a 38-year experience in the Netherlands. J. Hepatobiliary Pancreat. Sci. 2020; 27 (1): 26–33. https://doi.org/10.1002/jhbp.701</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Marudanayagam R., Shanmugam V., Sandhu B., Gunson B.K., Mirza D.F., Mayer D., Buckels J., Bramhall S.R. Liver retransplantation in adults: a single-centre, 25-year experience. HPB (Oxford). 2010; 12 (3): 217–224. https://doi.org/10.1111/j.1477-2574.2010.00162.x</mixed-citation><mixed-citation xml:lang="en">Marudanayagam R., Shanmugam V., Sandhu B., Gunson B.K., Mirza D.F., Mayer D., Buckels J., Bramhall S.R. Liver retransplantation in adults: a single-centre, 25-year experience. HPB (Oxford). 2010; 12 (3): 217–224. https://doi.org/10.1111/j.1477-2574.2010.00162.x</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Lladó L., Lopez-Dominguez J., Ramos E., Cachero A., Mils K., Baliellas C., Busquets J., Fabregat J. Is liver retransplantation justified in the current era? Cir. Esp. 2021; 99 (5): 339–345. https://doi.org/10.1016/j.ciresp.2020.06.023</mixed-citation><mixed-citation xml:lang="en">Lladó L., Lopez-Dominguez J., Ramos E., Cachero A., Mils K., Baliellas C., Busquets J., Fabregat J. Is liver retransplantation justified in the current era? Cir. Esp. 2021; 99 (5): 339–345. https://doi.org/10.1016/j.ciresp.2020.06.023</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Salimi J., Jafarian A., Fakhar N., Ramandi A., Behzadi M., Moeni A., Dashti H., Najafi A., Shariat M.R., Makarem J., Khamneh A.C. Study of re-transplantation and prognosis in liver transplant center in Iran. Gastroenterol. Hepatol. Bed. Bench. 2021; 14 (3): 237–242. PMID: 34221263; PMCID: PMC8245839</mixed-citation><mixed-citation xml:lang="en">Salimi J., Jafarian A., Fakhar N., Ramandi A., Behzadi M., Moeni A., Dashti H., Najafi A., Shariat M.R., Makarem J., Khamneh A.C. Study of re-transplantation and prognosis in liver transplant center in Iran. Gastroenterol. Hepatol. Bed. Bench. 2021; 14 (3): 237–242. PMID: 34221263; PMCID: PMC8245839</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
